Next Article in Journal
A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities
Next Article in Special Issue
Current Management and Future Perspectives in the Treatment of Lp(a) with a Focus on the Prevention of Cardiovascular Diseases
Previous Article in Journal
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic Treatment
 
 
pharmaceuticals-logo
Article Menu

Article Menu

Article

Article Versions Notes

Pharmaceuticals 2023, 16(6), 905; https://doi.org/10.3390/ph16060905
Action Date Notes Link
article xml file uploaded 20 June 2023 09:50 CEST Original file -
article xml uploaded. 20 June 2023 09:50 CEST Update -
article pdf uploaded. 20 June 2023 09:50 CEST Version of Record https://www.mdpi.com/1424-8247/16/6/905/pdf-vor
article html file updated 20 June 2023 09:52 CEST Original file -
article xml file uploaded 21 June 2023 04:27 CEST Update -
article xml uploaded. 21 June 2023 04:27 CEST Update https://www.mdpi.com/1424-8247/16/6/905/xml
article pdf uploaded. 21 June 2023 04:27 CEST Updated version of record https://www.mdpi.com/1424-8247/16/6/905/pdf
article html file updated 21 June 2023 04:29 CEST Update -
article html file updated 21 June 2023 04:29 CEST Update -
article html file updated 6 July 2023 20:56 CEST Update https://www.mdpi.com/1424-8247/16/6/905/html
Back to TopTop